차종호 (인하대학교 의과대학 의생명학교실)님 | 한빛사연구자 > 한빛사

인하대학교 의과대학 의생명학교실

CV File

최종업데이트 2026.01.30.

- 차종호(University of Texas MD Anderson Cancer Center, 인하대학교 의과대학 의생명학교실)
New Approaches on Cancer Immunotherapy
- Cold Spring Harb. Perspect. Med., Aug 03 2020, 10 (8) a036863 | https://doi.org/10.1101/cshperspect.a036863
- 2020-08
- 의약학
- 상위피인용논문
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
- Nat. Commun., Jan 03 2025, 16 (1) 353 | https://doi.org/10.1038/s41467-024-54132-1
- 2025-01
- 의약학
- 한빛사논문
PD-L1: From Cancer Immunotherapy to Therapeutic Implications in Multiple Disorders
- Mol. Ther., Sep 27 2024, S1525-0016(24)00650-6 | https://doi.org/10.1016/j.ymthe.2024.09.026
- 2024-09
- 의약학
- 한빛사논문, 상위피인용논문
- 차종호(인하대학교, University of Texas MD Anderson Cancer Center)
Mechanisms controlling PD-L1 expression in cancer
- Mol. Cell, Published:October 24, 2019 | https://doi.org/10.1016/j.molcel.2019.09.030
- 2019-10
- 한빛사논문, 상위피인용논문
- 차종호(서울대학교, University of Texas MD Anderson Cancer Center)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- Mol. Cell, 71, 606-620 August 16, 2018 | DOI:https://doi.org/10.1016/j.molcel.2018.07.030
- 2018-08
- 한빛사논문, 상위피인용논문
Prompt meningeal reconstruction mediated by oxygen-sensitive AKAP12 scaffolding protein after central nervous system injury
- Nat. Commun., 17 September 2014 | doi:10.1038/ncomms5952
- 2014-09
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기